Amy James Loftis

1.2k total citations · 1 hit paper
8 papers, 321 citations indexed

About

Amy James Loftis is a scholar working on Infectious Diseases, Epidemiology and Sociology and Political Science. According to data from OpenAlex, Amy James Loftis has authored 8 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 2 papers in Sociology and Political Science. Recurrent topics in Amy James Loftis's work include HIV/AIDS Research and Interventions (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Respiratory viral infections research (2 papers). Amy James Loftis is often cited by papers focused on HIV/AIDS Research and Interventions (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Respiratory viral infections research (2 papers). Amy James Loftis collaborates with scholars based in United States, South Africa and Botswana. Amy James Loftis's co-authors include William A. Fischer, David A. Wohl, Katie R. Mollan, Masoud Azizad, Katyna Borroto–Esoda, Wendy Painter, Ralph S. Baric, Myron S. Cohen, Robert W. Coombs and Lei Fang and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Science Translational Medicine.

In The Last Decade

Amy James Loftis

8 papers receiving 311 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

2021 230 citations William A. Fischer, Joseph J. Eron et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy James Loftis United States	6	277	84	41	33	23	8	321
Vincent Madelain France	10	403 1.5×	154 1.8×	41 1.0×	54 1.6×	15 0.7×	13	516
Nina Breinholt Stærke Denmark	7	130 0.5×	112 1.3×	27 0.7×	25 0.8×	21 0.9×	17	272
Derek L.L. Hung Hong Kong	6	173 0.6×	49 0.6×	50 1.2×	43 1.3×	12 0.5×	11	323
Samer Salih Saudi Arabia	6	131 0.5×	81 1.0×	17 0.4×	22 0.7×	5 0.2×	8	288
Ali Toloue Ostadgavahi Canada	7	159 0.6×	32 0.4×	33 0.8×	49 1.5×	8 0.3×	16	282
Amanda Kamali United States	11	154 0.6×	126 1.5×	20 0.5×	36 1.1×	4 0.2×	21	301
Asmita Gupte United States	7	174 0.6×	104 1.2×	20 0.5×	41 1.2×	20 0.9×	13	268
Sanjana Nair India	7	118 0.4×	34 0.4×	40 1.0×	99 3.0×	14 0.6×	12	308
Zehan Pang China	7	283 1.0×	65 0.8×	36 0.9×	120 3.6×	27 1.2×	7	447
Amy Slenker United States	5	252 0.9×	87 1.0×	44 1.1×	48 1.5×	13 0.6×	7	335

Countries citing papers authored by Amy James Loftis

Since Specialization

Citations

This map shows the geographic impact of Amy James Loftis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy James Loftis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy James Loftis more than expected).

Fields of papers citing papers by Amy James Loftis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy James Loftis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy James Loftis. The network helps show where Amy James Loftis may publish in the future.

Co-authorship network of co-authors of Amy James Loftis

This figure shows the co-authorship network connecting the top 25 collaborators of Amy James Loftis. A scholar is included among the top collaborators of Amy James Loftis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy James Loftis. Amy James Loftis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Azizad, Masoud, Cameron R. Wolfe, Amy James Loftis, et al.. (2022). A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. UNC Libraries. 2 indexed citations

2.

Fischer, William A., Joseph J. Eron, Wayne Holman, et al.. (2021). A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Science Translational Medicine. 14(628). eabl7430–eabl7430. 230 indexed citations breakdown →

3.

Chen, Jane S., Mitch Matoga, Gerald Tegha, et al.. (2020). Effects of Urethritis on Human Immunodeficiency Virus (HIV) in Semen: Implications for HIV Prevention and Cure. Clinical Infectious Diseases. 73(7). e2000–e2004. 3 indexed citations

4.

Theron, Gerhard, Grace Montepiedra, Katie McCarthy, et al.. (2020). Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus. Clinical Infectious Diseases. 72(11). e784–e790. 12 indexed citations

5.

Hoffman, Risa M., Meredith G. Warshaw, K. Rivet Amico, et al.. (2019). Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 83(1). 72–80. 6 indexed citations

6.

Bolton‐Moore, Carolyn, Edmund V. Capparelli, Pearl Samson, et al.. (2017). CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3–36 months with HIV infection. AIDS. 31(8). 1129–1136. 17 indexed citations

7.

Fischer, William A., Jerry Brown, David A. Wohl, et al.. (2017). Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection. Open Forum Infectious Diseases. 4(3). ofx155–ofx155. 39 indexed citations

8.

Loftis, Amy James, Kelly D. Chason, Marcia M. Hobbs, et al.. (2016). Validation of the Cepheid GeneXpert for Detecting Ebola Virus in Semen. The Journal of Infectious Diseases. 215(3). jiw562–jiw562. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact